Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)

Supplier Resources

Supplier Resources
Supplier Resources
Get access to resources for existing suppliers such as invoicing, financing and our supplier standards and expectations.

Johnson & Johnson Announces Plans to Separate Consumer Health Business

On November 12, 2021, Johnson & Johnson announced its intent to separate the Company’s Consumer Health business, creating two new market-leading companies. Following the planned separation, our Pharmaceutical and MedTech businesses would continue to operate as Johnson & Johnson. The announcement can be found here.

As part of preparatory steps, we are moving into a period of separating contracts, where necessary, for our supplier partners to effectively continue to do business with the two planned new companies. As always, we value your partnership, and we look forward to these conversations.

Please wait to hear from us as we address this work throughout 2022. If you have questions, please contact your Procurement partner directly.

Supporting economic inclusion and job creation for underserved populations by partnering with an inclusive and diverse supplier base
Our Credo Integrity Line is an integral component of our strong culture of integrity at Johnson & Johnson. It provides a channel for anyone (including employees, business partners, customers, consumers and others) to report potential violations of the Code of Business Conduct, other company policies or applicable laws and regulations in our countries of operation.

More from Johnson & Johnson

This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
Close cookie banner icon
Back to top
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue